Notice of Application to Register a Trade Name Product (Notice No. MPI 115)
Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:
Trade Name: Nobivac NXT HC
Reference: A012273
Active Ingredients and Concentrations:
Each dose (0.5 mL) of reconstituted vaccine contains:
Live attenuated feline herpesvirus type 1, strain G2620A: 105.8 – 107.1 PFU*
Live attenuated feline calicivirus, strain F9: 104.6 – 107.0 PFU*
*Plaque forming units.
Formulation Type: lyophilisate and solvent/diluent for suspension for injection
Application method/administration route: Subcutaneous use. Reconstitute the vial containing the lyophilisate with the supplied diluent. Reconstituted product will be an off-pink or pink coloured suspension. Ensure that the lyophilisate is completely reconstituted before use. Administer the total contents (0.5mL) of the vial.
Use Claim:
For the active immunisation of cats:
Any person may make a written submission to the Director-General concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.
The following address is:
ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.
MPI encourages submission by email.
The applicant’s address for service is:
33 Whakatiki Street, Upper Hutt 5018. Postal Address: Private Bag 908, Upper Hutt 5018.
Dated at Wellington this 26th day of March 2026.
SHALEEN NARAYAN Manager Approvals, Ministry for Primary Industries (acting under delegated authority).